Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285392160> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W4285392160 endingPage "5392" @default.
- W4285392160 startingPage "5383" @default.
- W4285392160 abstract "Psoriasis is an autoimmune inflammatory skin disorder that affects 2–3% of the world's population. It has distinct features, such as accelerated keratinocyte proliferation and proinflammatory cytokines secretion. Topical, systemic, phototherapy, and biologic therapies are used in the treatment. Topical therapies are preferred over systemic medicines for mild to moderate psoriasis. Systemic therapies are best for severe pathological conditions. Immunosuppressants, biological agents, and recently licensed phosphodiesterase-4 (PDE4) inhibitors are some of the systemic therapies. Present therapies have a lot of drawbacks, and new discoveries in the pathogenesis of psoriasis are opening the way for novel therapeutics that target the disease at the molecular level. Multiple small molecules, PDE-4 inhibitors, biologics, and immunomodulators, as well as newly discovered Janus kinases (JAK) inhibitors, were found to be effective. This article focuses on many emerging treatments as well as presently approved psoriasis medications." @default.
- W4285392160 created "2022-07-14" @default.
- W4285392160 creator A5014198300 @default.
- W4285392160 creator A5027650999 @default.
- W4285392160 creator A5080595588 @default.
- W4285392160 date "2022-07-13" @default.
- W4285392160 modified "2023-10-01" @default.
- W4285392160 title "Newly discovered biologic agent used for psoriasis treatment" @default.
- W4285392160 doi "https://doi.org/10.53730/ijhs.v6ns6.10667" @default.
- W4285392160 hasPublicationYear "2022" @default.
- W4285392160 type Work @default.
- W4285392160 citedByCount "0" @default.
- W4285392160 crossrefType "journal-article" @default.
- W4285392160 hasAuthorship W4285392160A5014198300 @default.
- W4285392160 hasAuthorship W4285392160A5027650999 @default.
- W4285392160 hasAuthorship W4285392160A5080595588 @default.
- W4285392160 hasBestOaLocation W42853921601 @default.
- W4285392160 hasConcept C112392421 @default.
- W4285392160 hasConcept C164027704 @default.
- W4285392160 hasConcept C203014093 @default.
- W4285392160 hasConcept C2776914184 @default.
- W4285392160 hasConcept C2777575956 @default.
- W4285392160 hasConcept C2778690821 @default.
- W4285392160 hasConcept C2778886723 @default.
- W4285392160 hasConcept C2780564577 @default.
- W4285392160 hasConcept C71924100 @default.
- W4285392160 hasConceptScore W4285392160C112392421 @default.
- W4285392160 hasConceptScore W4285392160C164027704 @default.
- W4285392160 hasConceptScore W4285392160C203014093 @default.
- W4285392160 hasConceptScore W4285392160C2776914184 @default.
- W4285392160 hasConceptScore W4285392160C2777575956 @default.
- W4285392160 hasConceptScore W4285392160C2778690821 @default.
- W4285392160 hasConceptScore W4285392160C2778886723 @default.
- W4285392160 hasConceptScore W4285392160C2780564577 @default.
- W4285392160 hasConceptScore W4285392160C71924100 @default.
- W4285392160 hasLocation W42853921601 @default.
- W4285392160 hasOpenAccess W4285392160 @default.
- W4285392160 hasPrimaryLocation W42853921601 @default.
- W4285392160 hasRelatedWork W2069013321 @default.
- W4285392160 hasRelatedWork W2164486346 @default.
- W4285392160 hasRelatedWork W2966945493 @default.
- W4285392160 hasRelatedWork W2980414489 @default.
- W4285392160 hasRelatedWork W3005096969 @default.
- W4285392160 hasRelatedWork W3012317406 @default.
- W4285392160 hasRelatedWork W3035511625 @default.
- W4285392160 hasRelatedWork W3130719820 @default.
- W4285392160 hasRelatedWork W3211102191 @default.
- W4285392160 hasRelatedWork W4285392160 @default.
- W4285392160 isParatext "false" @default.
- W4285392160 isRetracted "false" @default.
- W4285392160 workType "article" @default.